Competition Law Update: China and ASEAN Sign Cross-Border Competition Enforcement Agreement — Key Takeaways

Date:

Share post:

China and ASEAN Sign Landmark Cross-Border Competition Enforcement Agreement — What Foreign Companies Must Know

On March 18, 2025, China’s State Administration for Market Regulation (SAMR) and the 10 member states of ASEAN formally signed the China-ASEAN Competition Enforcement Cooperation Agreement, creating the first binding cross-border competition enforcement framework between China and a multilateral bloc. The agreement covers information sharing, case coordination, and joint investigation protocols affecting an estimated 35,000+ cross-border transactions annually between China and ASEAN markets.

For foreign executives operating in both markets, this agreement fundamentally reshapes compliance risk. In 2024 alone, SAMR reviewed 3,847 merger filings and issued RMB 45.2 billion in penalties for competition law violations. ASEAN members collectively handled 1,200+ enforcement actions in the same period. The new coordination framework means that a single transaction or conduct can now trigger parallel investigations in China and up to 10 ASEAN jurisdictions simultaneously.

Key Chinese terms: 竞争执法合作 (competition enforcement cooperation, jìngzhēng zhífǎ hézuò), 反垄断法 (Anti-Monopoly Law, fǎnlǒngduàn fǎ), 东盟 (ASEAN, Dōngméng).

What the Agreement Covers — And What It Changes

The agreement establishes six cooperation pillars: (1) notification of concurrent investigations, (2) information sharing with confidentiality safeguards, (3) coordinated dawn raids and evidence collection, (4) joint leniency program processing, (5) technical assistance and capacity building, and (6) dispute resolution mechanisms. Each pillar includes specific timelines — for instance, signatories must notify each other within 15 business days of opening an investigation that affects another party’s market.

The practical impact is immediate. Previously, a company facing a SAMR merger review for a China-ASEAN deal could assume ASEAN-level filings were independent. Under the new framework, SAMR can now request — and receive — case documents from Singapore’s Competition and Consumer Commission (CCCS) or Indonesia’s KPPU during its own review. This reduces duplication but increases the risk of conflicting remedies.

Notably, the agreement includes a positive comity provision: if anticompetitive conduct in ASEAN harms Chinese consumers, SAMR can request that ASEAN authorities take enforcement action on China’s behalf, and vice versa. This represents a significant escalation from the previous “best efforts” arrangement under the 2019 China-ASEAN MOU, which had no binding enforcement protocol.

Impact on Cross-Border M&A and Joint Ventures

For transactions that trigger filing thresholds in both China and one or more ASEAN jurisdictions, the new agreement creates a single coordinated review track in theory, but fragmented timelines in practice. SAMR’s Phase II review typically takes 90–120 additional days, while Singapore’s CCCS completes most reviews within 30–60 working days. The agreement does not harmonize these timelines — it only requires signatories to “consider” scheduling coordination.

This creates a critical strategic consideration: companies can no longer sequence filings to minimize overall delay. If SAMR extends its review, ASEAN authorities are now encouraged to hold their decision pending China’s outcome. In practice, this means total review time for a China-ASEAN deal could extend to 8–12 months, up from a historical average of 4–6 months for separate filings.

Joint ventures face particular scrutiny. The agreement identifies “structural links between parent companies across jurisdictions” as a priority enforcement area, meaning that competition authorities will share information about common ownership structures. A parent company with holdings in both a Chinese subsidiary and an ASEAN competitor now faces coordinated review of whether those holdings create coordination risks.

Comparison: Competition Law Frameworks Across China and Key ASEAN Jurisdictions

Jurisdiction Merger Notification Threshold Review Timeline (Standard) Penalty Range (Max) Leniency Program
China (SAMR) Global turnover > RMB 10B OR each party > RMB 400M in China 180 days (Phase I + II) Up to 10% of prior year revenue First-filer immunity + second-filer 50% reduction
Singapore (CCCS) Global turnover > SGD 100M AND local turnover > SGD 10M 30–60 working days Up to 10% of annual turnover for up to 3 years First-filer immunity + subsequent 20–50% reduction
Indonesia (KPPU) Asset value > IDR 2.5T OR turnover > IDR 5T 60–90 working days Up to 50% of profits or IDR 100B Discretionary reduction (no fixed formula)
Vietnam (VCA) Enterprise value > VND 3T OR market share > 50% 45–90 working days Up to 5% of prior year revenue First-filer immunity + second-filer 40% reduction
Thailand (OTC) Post-merger market share > 50% OR THB 1B turnover 90–120 days Up to 10% of annual turnover First-filer immunity + subsequent up to 50% reduction

Source: SAMR, CCCS, KPPU, VCA, OTC official publications, February 2025.

The table reveals a critical gap: filing thresholds differ dramatically. A mid-market deal with RMB 8 billion in global turnover may trigger notification in Singapore (if local revenue exceeds SGD 10 million) but fall below China’s RMB 10 billion threshold. Under the new agreement, authorities can request information about such transactions even if no formal notification is required — creating a voluntary notification risk for deals that historically flew under the radar.

Decision Framework: Prioritizing Your Compliance Approach

If your transaction involves combined global revenue above RMB 15 billion AND operations in three or more ASEAN jurisdictions, choose a single coordinated filing strategy with a single lead counsel managing parallel submissions across all relevant authorities. The agreement’s information-sharing provisions make separate, uncoordinated filings in each jurisdiction a high-risk approach — inconsistencies in market definition or remedy proposals across filings can now be cross-referenced by authorities.

If your transaction involves revenue between RMB 2 billion and RMB 10 billion with operations in only one or two ASEAN markets, choose a jurisdiction-by-jurisdiction risk assessment first, then determine which filings are mandatory and which may be voluntarily advisable. The agreement’s notification obligations are triggered only when an investigation is formally opened — pre-filing consultations remain confidential and do not trigger cross-border information sharing.

If your business involves ongoing commercial conduct (resale price maintenance, exclusive dealing, or abuse of dominance) that affects both China and ASEAN markets, choose a single global competition compliance program that harmonizes risk assessment criteria across all relevant jurisdictions. The positive comity provision means a competitor complaint in Thailand can now trigger coordinated investigations across multiple ASEAN states and potentially China itself.

Three Critical Pitfalls for Foreign Companies

Pitfall: Assuming that failing to trigger any single jurisdiction’s filing threshold means no risk exists. Under Article 4 of the new agreement, authorities can request “market information” about any transaction involving parties active in both markets, regardless of notification status. Cost: RMB 2–8 million in unexpected investigation costs plus potential penalties of up to 10% of revenue if non-notification is later deemed deliberate. Fix: Conduct a cross-border pre-filing assessment using the CG360 Competition Threshold Analyzer before closing any China-ASEAN transaction.
Pitfall: Applying a separate leniency application in China without coordinating with ASEAN filings. Under the agreement’s joint leniency protocol, authorities share the timing and content of leniency applications. A company that applies for leniency in China but delays in Singapore loses coordination benefits. Cost: Loss of second-filer leniency reductions worth 20–50% of penalties, potentially RMB 10–100 million. Fix: File leniency applications simultaneously across all affected jurisdictions within the same business day, using a single coordinated legal team.
Pitfall: Treating dawn raid preparedness as a country-by-country exercise. The agreement explicitly permits “coordinated unannounced inspections” where SAMR and ASEAN authorities can conduct simultaneous raids at related premises. Cost: RMB 500,000–5 million in legal fees for emergency response plus potential evidence spoliation penalties if employees are not trained for multi-jurisdiction raids. Fix: Implement a standardized dawn raid protocol across all China and ASEAN offices, with trained local response teams and 24/7 legal counsel availability.

What This Means for Your 2025–2026 Compliance Budget

The agreement’s implementation timeline is aggressive. Phase I (information sharing protocols) takes effect July 1, 2025. Phase II (joint investigation coordination) begins January 1, 2026. Foreign companies active in China-ASEAN trade should budget for:

  • Compliance program overhaul: RMB 800,000–1.5 million to integrate China and ASEAN competition law risk assessment into a single framework
  • Cross-border legal retainer: RMB 1.2–2.5 million annually for counsel with proven experience in both SAMR proceedings and ASEAN competition authority interactions
  • Executive training: RMB 150,000–300,000 for board-level and senior management training on coordinated investigation risks and positive comity exposure

Early adopters who complete compliance integration before Phase II takes effect gain a significant competitive advantage — they can respond to coordinated investigations in hours rather than weeks, reducing penalty exposure by an estimated 30–50% based on historical comparable cases.

NEXT STEPS

  1. Audit your existing transaction pipeline against the new filing thresholds — review all active M&A, JV, and distribution agreements involving China and any ASEAN market using our Competition Threshold Assessment Tool.
  2. Reassess your leniency program coordination — ensure your global compliance manual includes a single-protocol approach for multi-jurisdiction leniency applications, referencing our Cross-Border Leniency Guide for China-ASEAN 2025.
  3. Schedule a cross-border dawn raid drill — test your team’s ability to respond to simultaneous SAMR and ASEAN authority inspections using the CG360 Dawn Raid Preparedness Simulation.

— China Gateway 360 —
Remote China market entry support, built around execution.

Related articles

How a Foreign Biotech Startup Entered China’s Precision Medicine Market: Case Study

How a Foreign Biotech Startup Entered China's Precision Medicine Market: Case Study In 2023, NovaOnco Therapeutics, a US-based AI biotech startup, exe

How Legend Biotech Secured FDA Approval for CAR-T Therapy: Case Study

How Legend Biotech Secured FDA Approval for CAR-T Therapy: A China Biotech Case Study This case study examines how Legend Biotech (传奇生物, Legend Biotec

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study

How Innovent Biologics Achieved Global Clinical Trial Leadership: Case Study body{font-family:'Segoe UI',Tahoma,Geneva,Verdana,sans-serif;line-height:

How BeiGene Built a Billion-Dollar Biotech in China: Case Study

How BeiGene Built a Billion-Dollar Biotech in China: Case Study How BeiGene Built a Billion-Dollar Biotech in China: Case Study The story of BeiGene's